• Type 1 and 2 DM:
    • The dosage is individualized based on patient needs
    • Typical daily insulin requirements range between 0.4-1 unit/kg for Type 1

Cartridge/ Pre-filled syringe:

  • 70/30 (70% protaminated insulin aspart, 30% insulin aspart)
  • Administer subcutaneously in the abdominal area, thigh, upper arm or buttocks.
  • Rotate injection sites to avoid lipodystrophy.
  • Can be injected within 15 minutes before a meal.
  • Store unopened insulin in the refrigerator.
  • Once opened, it can be stored at room temperature for up to 28 days.

Insulin Aspart:  Rapid-acting insulin analog. It mimics the body’s natural insulin response to meals. It lowers blood glucose levels by enhancing the uptake of glucose into muscle and fat cells and suppressing liver glucose production.

Protaminated Insulin Aspart: An intermediate-acting insulin. It provides prolonged, basal insulin action by forming a crystalline suspension with protamine, which delays its absorption and offers extended blood glucose control throughout the day.

  • Hypoglycemia
  • Headache
  • Influenza-like symptoms
  • URI
  • Dyspepsia
  • Diarrhoea
  • Abdominal pain
  • Pruritus
  • Rash
  • Weight gain
  • Peripheral edema
  • Injection site reaction
  • Injection site lipodystrophy
  • Localised cutaneous amyloidosis
  • Hypersensitivity to drug or ingredient
  • IV use
  • Continuous SC infusion pump use
  • Hypoglycemia
  • Arsenic trioxide
  • Glucagon
  • Macimorelin
  • Repaglinide
  • Rosiglitazone

                                   Drug Status

Availability Prescription only
Pregnancy  Safe to use
Breastfeeding  Safe to use
Schedule Not controlled
BRAND NAME STRENGTH FORMULATION PACK SIZE MANUFACTURER DISTRIBUTOR
Novomix 30 Penfill 30/70 IU/mL Injection (cartridge) 5*3mL Novo Nordisk Phillips Therapeutics
Novomix 30 Flexpen 30/70 IU/mL Pre-Filled Syringe 5*3mL Novo Nordisk Phillips Therapeutics